secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001193125-23-208100
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics raises $80M in PIPE financing at $5.15 per share
-------------------------------------------------------------------

- Gross proceeds of ~$80M from sale of ~15.5M shares/pre-funded warrants at $5.15/share.
- Financing led by Nextech, with participation from Boxer Capital, Bain Capital Life Sciences, Casdin Capital, EcoR1 Capital, Southpoint Capital, Third Rock Ventures, and a large institutional investor.
- Proceeds expected to fund operations into 2026; extends runway for PRMT5 programs TNG908 and TNG462, and TNG260 trial.
- Pre-funded warrants exercisable at $0.0001, immediately exercisable; company to file resale registration statement by Sep 1, 2023.
- Directors and officers subject to 90-day lock-up agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312523208100/0001193125-23-208100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312523208100/d525614d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-208100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer